Oxford BioMedica PLC (OXB) — Cash Flow-to-Debt Ratio
Oxford BioMedica PLC (OXB) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of GBX2.35 Million could theoretically repay 0% of its total liabilities (GBX183.59 Million) in one year. See OXB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oxford BioMedica PLC Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Oxford BioMedica PLC across 28 annual periods. Also explore OXB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oxford BioMedica PLC (1996–2024)
Year-by-year debt coverage analysis for Oxford BioMedica PLC. For market capitalisation and broader financial context, see how much is Oxford BioMedica PLC worth.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.30x | GBX-50.63 Million | GBX171.16 Million | ▼ -81.0% |
| 2023 | -0.16x | GBX-28.52 Million | GBX174.51 Million | ▼ -190.2% |
| 2022 | -0.06x | GBX-12.62 Million | GBX223.99 Million | ▼ -111.0% |
| 2021 | 0.51x | GBX25.45 Million | GBX49.89 Million | ▲ +1065.5% |
| 2020 | 0.04x | GBX3.12 Million | GBX71.18 Million | ▲ +159.0% |
| 2019 | -0.07x | GBX-3.51 Million | GBX47.30 Million | ▼ -144.8% |
| 2018 | 0.17x | GBX12.87 Million | GBX77.66 Million | ▲ +229.6% |
| 2017 | 0.05x | GBX2.98 Million | GBX59.26 Million | ▲ +143.6% |
| 2016 | -0.12x | GBX-5.11 Million | GBX44.33 Million | ▲ +64.0% |
| 2015 | -0.32x | GBX-13.12 Million | GBX40.96 Million | ▲ +42.8% |
| 2014 | -0.56x | GBX-6.03 Million | GBX10.77 Million | ▲ +75.9% |
| 2013 | -2.32x | GBX-11.02 Million | GBX4.75 Million | ▼ -10.6% |
| 2012 | -2.10x | GBX-10.04 Million | GBX4.78 Million | ▼ -34.6% |
| 2011 | -1.56x | GBX-12.98 Million | GBX8.32 Million | ▼ -70.7% |
| 2010 | -0.91x | GBX-12.83 Million | GBX14.04 Million | ▼ -1007.1% |
| 2009 | 0.10x | GBX2.31 Million | GBX22.97 Million | ▲ +111.0% |
| 2008 | -0.91x | GBX-18.13 Million | GBX19.85 Million | ▼ -664.5% |
| 2007 | 0.16x | GBX4.73 Million | GBX29.23 Million | ▲ +105.1% |
| 2006 | -3.14x | GBX-17.13 Million | GBX5.45 Million | ▲ +0.5% |
| 2005 | -3.16x | GBX-8.34 Million | GBX2.64 Million | ▲ +32.8% |
| 2004 | -4.70x | GBX-10.37 Million | GBX2.21 Million | ▲ +26.4% |
| 2003 | -6.38x | GBX-9.58 Million | GBX1.50 Million | ▲ +21.9% |
| 2002 | -8.17x | GBX-10.30 Million | GBX1.26 Million | ▼ -64.4% |
| 2001 | -4.97x | GBX-8.73 Million | GBX1.76 Million | ▼ -36.0% |
| 2000 | -3.66x | GBX-4.90 Million | GBX1.34 Million | ▲ +18.2% |
| 1999 | -4.47x | GBX-3.58 Million | GBX801.00K | ▲ +36.3% |
| 1998 | -7.03x | GBX-3.37 Million | GBX480.00K | ▼ -3588.1% |
| 1996 | -0.19x | GBX-24.00K | GBX126.00K | — |